Bridgeway Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bridgeway Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.33M	Buy	40,500 +3,000	+8%	+$172K	0.04%	521
2026 Q1	$2.27M	Hold	37,500	–	–	0.05%	494
2025 Q4	$2.02M	Sell	37,500 -300	-0.8%	-$14.4K	0.04%	535
2025 Q3	$1.7M	Hold	37,800	–	–	0.04%	587
2025 Q2	$1.75M	Sell	37,800 -400	-1%	-$19.6K	0.04%	550
2025 Q1	$2.33M	Buy	+38,200	New	+$2.23M	0.06%	451
2024 Q4	–	Sell	-29,700	Closed	-$1.54M	–	1212
2024 Q3	$1.54M	Sell	29,700 -2,179	-7%	-$102K	0.03%	574
2024 Q2	$1.32M	Buy	+31,879	New	+$1.43M	0.03%	611
2022 Q4	–	Sell	-150,379	Closed	-$10.7M	–	1380
2022 Q3	$10.7M	Sell	150,379 -86,800	-37%	-$6.3M	0.29%	65
2022 Q2	$18.3M	Sell	237,179 -32,300	-12%	-$2.46M	0.42%	17
2022 Q1	$19.7M	Sell	269,479 -24,850	-8%	-$1.67M	0.38%	26
2021 Q4	$18.4M	Buy	294,329 +8,800	+3%	+$516K	0.34%	45
2021 Q3	$16.9M	Sell	285,529 -31,700	-10%	-$2.09M	0.32%	55
2021 Q2	$21.2M	Sell	317,229 -2,325	-0.7%	-$152K	0.38%	46
2021 Q1	$20.2M	Buy	319,554 +97,125	+44%	+$6.04M	0.38%	50
2020 Q4	$13.8M	Sell	222,429 -194,800	-47%	-$12M	0.29%	101
2020 Q3	$25.2M	Buy	+417,229	New	+$25.1M	0.58%	28
2016 Q4	–	Sell	-3,879	Closed	-$209K	–	1409
2016 Q3	$209K	Hold	3,879	–	–	﹤0.01%	1311
2016 Q2	$285K	Hold	3,879	–	–	﹤0.01%	1228
2016 Q1	$248K	Buy	+3,879	New	+$245K	﹤0.01%	1260

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bridgeway Capital Management's BMY Position: Q2 2026 in Review

Bridgeway Capital Management increased its Bristol-Myers Squibb (BMY) stake by 8% in Q2 2026, buying an estimated $172K and bringing the position to 40,500 shares worth $2.33M. The position accounts for 0.04% of the portfolio, ranked #521.

Bridgeway Capital Management first reported a position in BMY in Q1 2016 and has held it in 20 quarters since. The position peaked at $25.2M in Q3 2020. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Bridgeway Capital Management held 40,500 shares of Bristol-Myers Squibb worth $2.33M as of Q2 2026.
Bridgeway Capital Management bought 3,000 Bristol-Myers Squibb shares in Q2 2026, an estimated $172K.
Bristol-Myers Squibb made up 0.04% of Bridgeway Capital Management's portfolio in Q2 2026, its #521 holding.
Bridgeway Capital Management first reported a position in Bristol-Myers Squibb in Q1 2016 and has held it in 20 quarters since.
Bridgeway Capital Management's Bristol-Myers Squibb position peaked at $25.2M in Q3 2020.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.